Total Payments
$860,306
2024 Payments
$116,431
Companies
19
Transactions
1,134
Payment Breakdown by Category
Other$691,911 (80.4%)
Travel$137,232 (16.0%)
Food & Beverage$21,712 (2.5%)
Consulting$9,450 (1.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $691,086 | 238 | 80.3% |
| Travel and Lodging | $137,232 | 511 | 16.0% |
| Food and Beverage | $21,712 | 380 | 2.5% |
| Consulting Fee | $9,450 | 3 | 1.1% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $600.00 | 1 | 0.1% |
| Honoraria | $225.00 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $756,236 | 891 | $0 (2024) |
| Grifols USA, LLC | $84,107 | 160 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $9,714 | 29 | $0 (2018) |
| Boston Scientific Corporation | $4,819 | 7 | $0 (2023) |
| EKOS Corporation | $3,685 | 3 | $0 (2017) |
| ViiV Healthcare Company | $600.00 | 1 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $485.13 | 14 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $125.00 | 1 | $0 (2017) |
| Gilead Sciences, Inc. | $122.33 | 8 | $0 (2019) |
| Vapotherm Inc | $101.05 | 4 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $116,431 | 156 | GlaxoSmithKline, LLC. ($116,249) |
| 2023 | $189,249 | 272 | GlaxoSmithKline, LLC. ($189,116) |
| 2022 | $132,096 | 140 | GlaxoSmithKline, LLC. ($132,075) |
| 2021 | $119,397 | 126 | GlaxoSmithKline, LLC. ($119,397) |
| 2020 | $88,832 | 87 | GlaxoSmithKline, LLC. ($88,671) |
| 2019 | $116,047 | 126 | GlaxoSmithKline, LLC. ($110,308) |
| 2018 | $43,697 | 104 | Grifols USA, LLC ($37,338) |
| 2017 | $54,557 | 123 | Grifols USA, LLC ($41,667) |
All Payment Transactions
1,134 individual payment records from CMS Open Payments — Page 1 of 46
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: RESPIRATORY | ||||||
| 12/18/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,950.00 | General |
| Category: RESPIRATORY | ||||||
| 12/05/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Travel and Lodging | Cash or cash equivalent | $121.43 | General |
| Category: RESPIRATORY | ||||||
| 12/05/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Travel and Lodging | Cash or cash equivalent | $121.43 | General |
| Category: RESPIRATORY | ||||||
| 12/05/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | Cash or cash equivalent | $77.03 | General |
| Category: RESPIRATORY | ||||||
| 12/05/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $21.99 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Travel and Lodging | Cash or cash equivalent | $10.00 | General |
| Category: RESPIRATORY | ||||||
| 12/05/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | Cash or cash equivalent | $7.11 | General |
| Category: RESPIRATORY | ||||||
| 12/04/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Travel and Lodging | In-kind items and services | $213.38 | General |
| Category: RESPIRATORY | ||||||
| 12/04/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $119.79 | General |
| Category: RESPIRATORY | ||||||
| 12/04/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Travel and Lodging | In-kind items and services | $5.00 | General |
| Category: RESPIRATORY | ||||||
| 11/12/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Travel and Lodging | In-kind items and services | $277.10 | General |
| Category: RESPIRATORY | ||||||
| 11/12/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $33.12 | General |
| Category: RESPIRATORY | ||||||
| 11/12/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $7.87 | General |
| Category: RESPIRATORY | ||||||
| 11/12/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Travel and Lodging | In-kind items and services | $5.00 | General |
| Category: RESPIRATORY | ||||||
| 10/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $28.22 | General |
| Category: RESPIRATORY | ||||||
| 09/20/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: RESPIRATORY | ||||||
| 09/11/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | Cash or cash equivalent | $85.70 | General |
| Category: RESPIRATORY | ||||||
| 09/11/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Travel and Lodging | Cash or cash equivalent | $79.33 | General |
| Category: RESPIRATORY | ||||||
| 08/22/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Travel and Lodging | In-kind items and services | $1,344.46 | General |
| Category: RESPIRATORY | ||||||
| 08/22/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Travel and Lodging | In-kind items and services | $211.59 | General |
| Category: RESPIRATORY | ||||||
| 08/22/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $121.92 | General |
| Category: RESPIRATORY | ||||||
| 08/12/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,550.00 | General |
| Category: RESPIRATORY | ||||||
| 07/19/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,625.00 | General |
| Category: IMMUNOLOGY | ||||||
About Dr. Michael Ott, MD
Dr. Michael Ott, MD is a Pulmonary Disease healthcare provider based in Eglin Afb, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/01/2005. The National Provider Identifier (NPI) number assigned to this provider is 1629052725.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Ott, MD has received a total of $860,306 in payments from pharmaceutical and medical device companies, with $116,431 received in 2024. These payments were reported across 1,134 transactions from 19 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($691,086).
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Eglin Afb, FL
- Active Since 12/01/2005
- Last Updated 10/10/2025
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1629052725
Products in Payments
- TRELEGY ELLIPTA (Drug) $321,286
- AREXVY (Drug) $157,967
- NUCALA (Biological) $109,796
- Prolastin-C (Biological) $79,024
- ANORO ELLIPTA (Drug) $17,804
- ANORO (Drug) $9,770
- UTIBRON (Drug) $6,288
- Prolastin-C Liquid (Biological) $5,102
- EKOSONIC (Device) $3,685
- LONHALA MAGNAIR (Drug) $3,425
- ALAIR (Device) $2,663
- ALAIR BRONCHIAL THERMOPLASTY SYSTEM (Device) $2,025
- OFEV (Drug) $125.99
- CINQAIR (Drug) $125.00
- GENERAL - PULMONARY (Device) $117.34
- Precision Flow (Device) $101.05
- BREO (Drug) $98.54
- JARDIANCE (Drug) $64.64
- Epclusa (Drug) $60.25
- STIOLTO RESPIMAT (Drug) $44.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.